Dr. Brian R. Sperber, MD, PhD

Dr. Sperber practices at Colorado Springs Dermatology Clinic in Colorado Springs, Colorado.

Dr. Sperber's NPI, 1356437271, was assigned on October 5, 2006. Dr. Sperber graduated from Perelman School of Med at the University of Pennsylvania in 2002. Dr. Sperber holds Colorado license 44311.

Dr. Sperber's primary practice is Colorado Springs Dermatology Clinic, at 170 S Parkside Dr, Colorado Springs, CO 80910-3129. The practice phone is (719) 471-1763.

Dr. Sperber's primary practice is Colorado Springs Dermatology Clinic in Colorado Springs, Colorado. Dr. Sperber is also affiliated with UCHealth Memorial Hospital Central. The medical group on file is Colorado Springs Dermatology Clinic.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sperber practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Sperber's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Sperber is licensed in Colorado.

CMS data shows 7,122 Medicare services from Dr. Sperber across 25 procedure codes in 2024, for 1,248 Medicare patients. Medicare paid $321,799 for them. Every service was in an office.

CMS counts 1,248 Medicare patients who saw Dr. Sperber in 2024. The largest group is 65 to 74, with 594 patients. 73% of them have high cholesterol, and 59% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sperber's median patient age at 74, with 49% women.

In 2024, Dr. Sperber wrote 1,843 Medicare Part D claims for 594 patients. 93% of them were for generic drugs. CMS names the drug for 1,606 of them, across 36 drugs with 11 or more claims each, at $386,366 in total drug cost. In 2023, CMS named 1,476 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Sperber for performance year 2024, reported as part of a group. Dr. Sperber accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,688 procedures of removal of skin lesions by Dr. Sperber, more than 97% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Sperber, published from 2012 to 2014. The most frequent topics are Adalimumab, Antibodies, Monoclonal, Humanized and Anti-Inflammatory Agents. Dr. Sperber's most frequent co-authors are Bruce A. Brod, MD, Joel M. Gelfand, MD and Robert E. Kalb, MD.

CMS Open Payments shows 440 general payments to Dr. Sperber from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 51% of the total. Sanofi and Genzyme US Companies paid the most, $8,446.

Dr. Sperber graduated from Perelman School of Med at the University of Pennsylvania in 2002.